Those of you who have been shifting investments to international, does todays pharmaceutical EO change your plans?

It seems like the drug manufacturers are not going to suddenly give up 60% of their profits or whatever amount of that comes from the US, so it seems like the most likely outcome is that drug prices will increase substantially in the EU, Australia and other places with nationalized healthcare. Seems like that has a huge drag potential on their economies. Do you still expect international investing to outperform over the near term? Long term?

My two cents, I have not and do not invest internationally, I invest in large cap US indexes and the largest companies in those indexes already have large international exposure so I don't see the value in further expanding my international exposure. I have not changed my investing philosophy regardless of presidential party affiliation.